FY2025 · ended Dec 31, 2025 · Revenue $526.52M, +0.5% YoY · Filed Mar 23, 2026
Core Laboratories Inc. (CLB) files with the SEC under industry code 1389, Oil & Gas Field Services, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $526.5 million and net income of $29.7 million. Free cash flow was $25.8 million. As of Sep 30, 2026 it held $21.4 million in cash and investments and $164.3 million in total debt.
Revenue (TTM)
$516.74M
-0.1% vs year-ago TTM
Net income (TTM)
$15.56M
-51.6% vs year-ago TTM
Operating cash flow (TTM)
$24.69M
-50.3% vs year-ago TTM
Free cash flow (TTM)
$10.36M
-72.9% vs year-ago TTM
EPS (TTM)
$0.33
-50.7% vs year-ago TTM
Dividend per share (TTM)
$0.04
+0.0% vs year-ago TTM
Shares outstanding
46.05M
-1.7% vs prior year
Net cash
$-142.90M
as of Sep 30, 2026
Operating margin
7.5%
FY 2026
Company profile
- Industry
- Oil & Gas Field Services, NEC (SIC 1389)
- Listed as
- CLB (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1958086
- Former names
- Core Laboratories Luxembourg S.A. (until Feb 28, 2023)
Other Oil & Gas Field Services, NEC companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
|---|---|---|---|
| Revenue | $526.5M | $523.8M | $509.8M |
| Operating income | $56.5M | $58.6M | $54.6M |
| Net income | $29.7M | $31.4M | $36.7M |
| Diluted EPS | $0.63 | $0.66 | $0.77 |
| Operating cash flow | $37.0M | $56.4M | $24.8M |
| Free cash flow | $25.8M | $44.5M | $14.2M |
| Total assets | $584.0M | $585.1M | $586.4M |
| Stockholders' equity | $266.0M | $246.6M | $224.8M |
| Cash and investments | $22.7M | $19.2M | $15.1M |
| Total debt | $166.8M | $182.0M | $218.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 25, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 13, 2026 | May 12, 2026 |
All 186 Core Laboratories Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.